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Xanthogranulomatous inflammation is a rare clinico-pathological condition involving many organ systems. Breast
involvement with this rare condition reported from a few cases of mastitis has been limited to only microscopic
involvement on histology. We would like to report an unusual presentation of this inflammatory process presenting
as a solid lump mimicking malignancy in latissimus dorsi donor site scar and implant-based breast reconstruction as
a result of a ruptured silicone gel implant. To our knowledge there have been no previous reports on similar
presentation published in the literature. This case highlights a rare complication of a leaked silicone gel implant
triggering a xanthomatous response in the absence of the usual infective or obstructing etiologies. This condition is
of benign nature with complete clearance on surgical excision and excellent clinical prognosis reported from other
organ involvement.Background
Xanthogranulomatous inflammation involves various
organ systems such as the gall bladder, kidney, pancreas,
appendix, eyes, female genital tracts, colon, and urachus
[1-8]; breast involvement seen with this inflammation has
been limited to only few rare cases of mastitis. We would
like to report an unusual involvement of this inflammatory
process presenting as a solid lump resembling a malig-
nancy in latissimus dorsi donor site scar and breast implant
in a previously treated breast cancer patient. Occurrence of
this inflammation from a ruptured implant and silicone gel
leak in not known; to our knowledge, there have been no
previous reports on similar presentations.
Case presentation
A 56-year-old lady presented with an abnormal mass
arising from her latissimus dorsi (LD) donor site scar
(Figure 1) and hardening of the left reconstructed breast.
She had no co-morbidities apart from anxiety disorder
and breast cancer treated 10 years ago. She had a left
mastectomy and immediate implant-assisted LD recon-
struction. The tumor was grade 3 estrogen receptor* Correspondence: tasadooq.hussain@gmail.com
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reproduction in any medium, provided the orpositive. The adjuvant treatment was chemotherapy and
an aromatase inhibitor (anastrazole). Her routine follow-
up was uneventful and she had been discharged.
On examination she had a 10 cm mass arising from
the donor site scar. The mass was well defined with an
area of softness on the anterior surface. The left recon-
structed breast had a marked capsular contracture
(Figure 2) and a superficially placed implant under the
thinned medial aspect of the LD flap. The donor site
scar changes were considered highly suspicious of cancer
recurrence or a new primary with no clinical evidence of
any recurrent disease in the left reconstructed breast
and axilla.
Initial investigation of the mass with ultrasound (US)
showed solid tissue within the mass with a central fluid
collection that on fine needle aspiration showed necrotic
debris. US findings were confirmed by the contrast-
enhanced computer tomography (CT) scan with no evi-
dence of any distant metastasis. A magnetic resonance
imaging (MRI) scan (Figure 3) of the breast and the
lump showed features of implant encapsulation and
nodularity, with areas of high-contrast uptake in the
breast reconstruction and LD scar suggesting breast can-
cer recurrence. The core biopsy of the back mass lesion
showed features of granular histiocytes mixed withl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Palpable abnormal lump arising in the latissimus dorsi (LD) donor site scar.
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clefts. These changes reflected a florid reactive inflam-
matory process of xanthomatous nature with no evi-
dence of any malignancy.
Excision biopsy of the back mass lesion and revision of
the reconstructed breast for definitive histological diag-
nosis was performed in two stages. In stage one, the
mass was excised with a transverse ellipse and the
wound closed with advancement flaps. The microscopic
appearances of the excised lesion were similar to core bi-
opsy findings with xanthoma-laden large macrophages
interlaced with inflammatory cells and no malignancy
(Figure 4). Findings of this nature on histology were
pointing towards a chronic inflammatory etiology sec-
ondary to possibly silicone leak from the breast implant.
The breast reconstruction was revised in the second
stage; operative findings confirmed rupture in the im-
plant with posterior tracking of silicone and features of
old hemorrhage. The leaking implant was removed andFigure 2 Abnormal looking left breast reconstruction with marked cacapsulectomy performed. The LD flap was medially
advanced and the breast reconstruction was completed
by using a style 150 expandable implant prosthesis.
Intra-operative characteristic yellow discoloration of
both the implant and capsule (Figure 5) indicated in-
volvement with strong xanthomatous inflammation.
These findings were confirmed later on histology with
no evidence of malignancy noted in the excised breast
tissue. The patient recovered well from both the proce-
dures and required no further treatment for the condi-
tion after final histology.
Xanthogranulomatous inflammation is a benign patho-
logical condition considered to be a primary disease
process of unknown etiology. Various organ system can
be involved to varying degrees; most commonly affected
are the kidneys and gall bladder with a few rare cases of
colonic involvement. Evidence of breast involvement
comes from cases of inflammatory mastitis [9] showing
features of xanthomatous change on microscopy. Therepsular contracture.
Figure 5 Operative specimen showing capsular xanthomas.
Figure 3 Magnetic resonance imaging (MRI) showing capsular
contracture of left breast implant and posterior latissimus dorsi
(LD) mass.
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the condition, with a few cases from an early pediatric
age group also noted [10].
The exact etiology of the disease is unknown; organ
obstruction, suppurative infections and hemorrhage trig-
ger tissue damage within the involved organs, usually
eliciting a microscopic response of the disease process.
The case study by Luc and colleagues [11] following long-
standing infections with mycoplasma hominis supports
the infective etiology theory of this condition. These trig-
gers, either on their own or synchronously (as postulated
in the obstructive hypothesis of gall bladder and kidney
pathologies), cause extensive chronic inflammation of theFigure 4 Photomicrograph of a hematoxylin and eosin slide
showing the characteristic appearances of
xanthogranulomatous inflammation. Sheets of histiocytes are
interspersed with multinucleate giant cells, empty cholesterol clefts
and yellow hematoidin pigment (original magnification × 40).involved organ resulting in a xanthogranulomatous trans-
formation. A similar obstructive trigger would also explain
the changes in xanthogranulomatous appendicitis follow-
ing chronic inflammation of the obstructed lumen with
faecolith.
Xanthogranulomatous inflammation disease presentation
is variable, with both localized and diffuse responses. A
diffuse inflammation is the more severe form of the disease,
resulting in a complete obliteration of the native parenchy-
mal tissue and marked fibrosis which clinically presents as
solid lumps. Xanthogranulomatous inflammationcan also
have a cutaneous involvement which can be primary or sec-
ondary [12]. Secondary disease represents a severe form of
an internal disease process and, clinically, patients present
with a discharging skin lesion that communicates through
an underlying fistula with the involved organ.
Radiological diagnosis of xanthogranulomatous inflam-
mation using US and CT is challenging. Diagnostic accur-
acy can be increased using contrast-based imaging, as
demonstrated using sonazoid contrast enhancing agent
with US scan in the diagnosis of chronic inflamed and
thickened gall bladders, and CT urography studies for
renal xanthogranulomatous inflammatory disease [13,14].
The characteristic findings on imaging are the areas of low
attenuation nodules corresponding to the xanthomatous
change on histology.
The microscopic appearances of xanthogranulomatous
inflammation on histology show the characteristic multi-
nucleate giant cells interspersed with lipid-laden macro-
phages which impart the characteristic yellow macroscopic
appearance. This appearance, however, should be differen-
tiated from a pseudo xanthomatous inflammation or mala-
koplakia characterized by Michaelis-Gutman bodies which
stain positive with Von Kossa calcium and Prussian blue
stains [15].
In our case, an implant leak triggered the inflamma-
tory process. Presentation of a well localized mass in the
LD back scar was a result of an extensive tissue
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leaked silicone. However, what surprisingly was absent
in our case was the postulated triggers of obstruction or
infection at surgery; gram staining of both implant and
back tissue was negative too. The pre-operative imaging
was mostly helpful in delineating the anatomy of the
mass and excluding any systemic spread from previously
treated breast primary; failure to accurately diagnose the
condition confirms the limitations of both CT and MRI
in these cases.
The recommended treatment of solid lumps with dif-
fuse involvement is usually surgical as this condition is
not pre-malignant [16]. A complete surgical excision
negates the need for any further treatment. There is no
evidence in the literature to support any recurrence in
the native or other organs following the primary surgical
treatment.
Conclusions
The silicone gel-filled breast implants are safe with a pro-
longed life span; however, implant-related problems
increases with time (usual complications are capsular con-
tractures, asymmetry and ruptures) and, therefore, sur-
geons should be wary of these unusual presentations when
dealing with the complications of long-standing implants.
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